Literature DB >> 7542400

Endocrine environment of benign prostatic hyperplasia: prostate size and volume are correlated with serum estrogen concentration.

K Suzuki1, K Ito, Y Ichinose, K Kurokawa, T Suzuki, K Imai, H Yamanaka, S Honma.   

Abstract

Estrogen plays an important role in the development of benign prostatic hyperplasia (BPH), as has been shown in both experimental and clinical studies. T determine the endocrine environment of BPH, serum total testosterone (Total-T), free testosterone (Free-T), and estradiol (E2) conceptions were measured, and the relationship between these levels and prostate size and volume was analyzed. Blood samples were collected from subjects who attended the mass screening for prostate disease performed by our institute. No significant correlations were found between Total-T levels, Free-T levels, and prostate size, as determined by digital rectal examination. However, E2 levels and the ratios for E2 levels and the ratios for E2/Total-T and E2/Free-T were significantly correlated with prostate size. To confirm these relationships, prostate volume was calculated from transrectal ultrasonographic images. E2 levels and these two ratios were, indeed, highly correlated with prostate volume. These results suggest that an estrogen-dominant environment plays an important role in the development of BPH.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542400     DOI: 10.3109/00365599509180541

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  6 in total

1.  Management of experimental benign prostatic hyperplasia in rats using a food-based therapy containing Telfairia occidentalis seeds.

Authors:  Chukwunonso E C C Ejike; Lawrence U S Ezeanyika
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-06-01

2.  Bisphenol-A analogs induce lower urinary tract dysfunction in male mice.

Authors:  J L Nguyen; E A Ricke; T T Liu; R Gerona; L MacGillivray; Z Wang; B G Timms; D E Bjorling; F S Vom Saal; W A Ricke
Journal:  Biochem Pharmacol       Date:  2022-01-01       Impact factor: 6.100

3.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Authors:  Alan R Kristal; Jeannette M Schenk; YoonJu Song; Kathryn B Arnold; Marian L Neuhouser; Phyllis J Goodman; Daniel W Lin; Frank Z Stanczyk; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2008-10-21       Impact factor: 4.897

4.  Endocrine disruptor bisphenol A is implicated in urinary voiding dysfunction in male mice.

Authors:  Tristan M Nicholson; Jalissa L Nguyen; Glen E Leverson; Julia A Taylor; Frederick S Vom Saal; Ronald W Wood; William A Ricke
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-18

5.  Autocrine androgen action is essential for Leydig cell maturation and function, and protects against late-onset Leydig cell apoptosis in both mice and men.

Authors:  Laura O'Hara; Kerry McInnes; Ioannis Simitsidellis; Stephanie Morgan; Nina Atanassova; Jolanta Slowikowska-Hilczer; Krzysztof Kula; Maria Szarras-Czapnik; Laura Milne; Rod T Mitchell; Lee B Smith
Journal:  FASEB J       Date:  2014-11-17       Impact factor: 5.191

6.  Upregulation of Oxytocin Receptor in the Hyperplastic Prostate.

Authors:  Zhuo Li; He Xiao; Kebing Wang; Yuelan Zheng; Ping Chen; Xinghuan Wang; Michael E DiSanto; Xinhua Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-03       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.